Cargando…

Incidence of Atrial Fibrillation in Persons with Very High Serum Levels of N-Terminal Pro-B-Type Natriuretic Peptide: The Multi-Ethnic Study of Atherosclerosis

OBJECTIVE: While persons in the upper fourth or fifth of the distribution of serum levels of N-terminal pro-B type natriuretic peptide (NT-proBNP) are at a sharply increased risk of developing atrial fibrillation, their absolute risk of this condition (about 20 per 1000 per year) is not clearly high...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weiss, Noel S, Perez Trejo, Esther, Kronmal, Richard, Lima, Joao, Heckbert, Susan R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039022/ https://www.ncbi.nlm.nih.gov/pubmed/33854380 http://dx.doi.org/10.2147/CLEP.S303560

Ejemplares similares

Association between N-terminal Pro-Brain Natriuretic Peptide levels, glomerular filtration rate, and heart failure in the Multi-Ethnic Study of Atherosclerosis
por: Syed, Daneyal, et al.
Publicado: (2018)

N-terminal Pro-Brain Natriuretic Peptide And Atrial Fibrillation
por: Thejus, Jayachandran, et al.
Publicado: (2009)

Relationship of atrial fibrillation and N terminal pro brain natriuretic peptide in heart failure patients
por: Nasab Mehrabi, Entezar, et al.
Publicado: (2023)

Associations of Left Atrial Function and Structure With Supraventricular Ectopy: The Multi‐Ethnic Study of Atherosclerosis
por: Heckbert, Susan R., et al.
Publicado: (2021)

Change in left atrial function predicts incident atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis
por: Lim, Daniel J, et al.
Publicado: (2019)

Blood Lipids and the Incidence of Atrial Fibrillation: The Multi‐Ethnic Study of Atherosclerosis and the Framingham Heart Study
por: Alonso, Alvaro, et al.
Publicado: (2014)

N‐Terminal Pro Brain, N‐Terminal Pro Atrial Natriuretic Peptides, and Dynamic Cerebral Autoregulation
por: Mahinrad, Simin, et al.
Publicado: (2020)

Peripheral Arterial Disease and Risk of Atrial Fibrillation and Stroke: The Multi‐Ethnic Study of Atherosclerosis
por: O'Neal, Wesley T., et al.
Publicado: (2014)

Clinical correlation between N-terminal pro-b-type natriuretic peptide and angiographic coronary atherosclerosis
por: Ribeiro, Demóstenes G. L., et al.
Publicado: (2014)

Assessment of N-terminal pro-B-type natriuretic peptide level in screening for atrial fibrillation in primary health care
por: Ghazal, Faris, et al.
Publicado: (2019)

N‐terminal pro brain natriuretic peptide eliminates the prognostic effect of atrial fibrillation in patients with chronic heart failure
por: Schnorbach, Johannes, et al.
Publicado: (2019)

Prediction of Atrial Fibrillation in a Racially Diverse Cohort: The Multi‐Ethnic Study of Atherosclerosis (MESA)
por: Alonso, Alvaro, et al.
Publicado: (2016)

Adhesion pathway proteins and risk of atrial fibrillation in the Multi-Ethnic Study of Atherosclerosis
por: Mendez, Israel J., et al.
Publicado: (2021)

Relationship of diabetes, heart failure, and N‐terminal pro‐B‐type natriuretic peptide with cardiovascular outcomes in patients with atrial fibrillation
por: Hofer, Felix, et al.
Publicado: (2022)

Carotid Intima‐Media Thickness and Arterial Stiffness and the Risk of Atrial Fibrillation: The Atherosclerosis Risk in Communities (ARIC) Study, Multi‐Ethnic Study of Atherosclerosis (MESA), and the Rotterdam Study
por: Chen, Lin Y., et al.
Publicado: (2016)

Correlation between N-Terminal Pro-Brain Natriuretic Peptide and Doppler Echocardiographic Parameters of Left Ventricular Filling Pressure in Atrial Fibrillation
por: Kim, Woo Shin, et al.
Publicado: (2011)

Plasma N-terminal pro-atrial natriuretic peptide concentrations are affected by dehydration in healthy dogs
por: Ogawa, Mizuki, et al.
Publicado: (2023)

N‐terminal pro‐B‐type natriuretic peptide and D‐dimer combined with left atrial diameter to predict the risk of ischemic stroke in nonvalvular atrial fibrillation
por: Shen, Zican, et al.
Publicado: (2022)

Association of right atrial structure with incident atrial fibrillation: a longitudinal cohort cardiovascular magnetic resonance study from the Multi-Ethnic Study of Atherosclerosis (MESA)
por: Xie, Eric, et al.
Publicado: (2020)

Racial and ethnic differences in circulating N-terminal pro-brain-type natriuretic peptide (NT-proBNP) in US adults
por: Commodore-Mensah, Yvonne, et al.
Publicado: (2023)

Natriuretic peptides for the detection of paroxysmal atrial fibrillation
por: Seegers, Joachim, et al.
Publicado: (2015)

Plasma atrial natriuretic peptide and N-terminal pro B-type natriuretic peptide concentrations in dogs with right-sided congestive heart failure
por: KANNO, Nobuyuki, et al.
Publicado: (2015)

N-Terminal Pro B-Type Natriuretic Peptide's Usefulness for Paroxysmal Atrial Fibrillation Detection Among Populations Carrying Cardiovascular Risk Factors
por: Palà, Elena, et al.
Publicado: (2019)

Supraventricular arrhythmia, N-terminal pro-brain natriuretic peptide and troponin T concentration in relation to incidence of atrial fibrillation: a prospective cohort study
por: Xiao, Jun, et al.
Publicado: (2021)

Effects of Atrial Fibrillation Screening According to N-Terminal Pro-B-Type Natriuretic Peptide: A Secondary Analysis of the Randomized LOOP Study
por: Xing, Lucas Yixi, et al.
Publicado: (2023)

Midregional pro-atrial natriuretic peptide is a superior biomarker to N-terminal pro-B-type natriuretic peptide in the diagnosis of heart failure patients with preserved ejection fraction
por: Cui, Kun, et al.
Publicado: (2018)

N-terminal pro atrial natriuretic peptide as a prognostic marker of cardiac resynchronization therapy recipients
por: Ueda, Nobuhiko, et al.
Publicado: (2023)

Pericardial fat volume and incident atrial fibrillation in the Multi-Ethnic Study of Atherosclerosis and Jackson Heart Study
por: Heckbert, Susan R., et al.
Publicado: (2017)

Impact of Body Mass Index on Plasma N-Terminal ProB-Type Natriuretic Peptides in Chinese Atrial Fibrillation Patients without Heart Failure
por: Zheng, Li-hui, et al.
Publicado: (2014)

Value of N-Terminal Pro-Brain Natriuretic Peptide for Embolic Events Risk Prediction in Patients with Atrial Fibrillation; a Systematic Review and Meta-Analysis
por: Ahmadzadeh, Koohyar, et al.
Publicado: (2023)

Predictive value of pre-procedural N-terminal pro-B-type natriuretic peptide level for atrial fibrillation recurrence after radiofrequency catheter ablation
por: Zhao, Qing, et al.
Publicado: (2023)

The association of novel inflammatory marker GlycA and incident atrial fibrillation in the Multi-Ethnic Study of Atherosclerosis (MESA)
por: Jang, Sunyoung, et al.
Publicado: (2021)

Utility of point-of-care testing of natriuretic peptides (brain natriuretic peptide and n-terminal pro-brain natriuretic peptide) in the emergency department
por: Nayer, Jamshed, et al.
Publicado: (2014)

N-terminal pro-brain natriuretic peptide levels had an independent and added ability in the evaluation of all-cause mortality in older Chinese patients with atrial fibrillation
por: Fu, Shihui, et al.
Publicado: (2019)

Effect of Pancreatic Hormones on pro-Atrial Natriuretic Peptide in Humans
por: Zois, Nora E., et al.
Publicado: (2017)

Impact of Midregional N‐Terminal Pro–Atrial Natriuretic Peptide and Soluble Suppression of Tumorigenicity 2 Levels on Heart Rhythm in Patients Treated With Catheter Ablation for Atrial Fibrillation: The Biorhythm Study
por: Badoz, Marc, et al.
Publicado: (2021)

NH(2)-Terminal Pro–Brain Natriuretic Peptide and Risk of Diabetes
por: Lazo, Mariana, et al.
Publicado: (2013)

N-terminal pro brain natriuretic peptide in coronary artery disease
por: Tin, Sim Sai, et al.
Publicado: (2015)

N-Terminal Pro–B-Type Natriuretic Peptide and Incident CKD
por: Sasaki, Takaya, et al.
Publicado: (2021)

N-terminal-pro brain natriuretic peptides in dogs and cats: A technical and clinical review
por: de Lima, Gabriela Vieira, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ps8lp6pod11tc99u8gb9fi4u3d